0.71 USD
▲+0.04+3.32%
盘后 0.67 -2.80%
2026-08-03
市值
$192.04M
市盈率
—
EPS
-0.55
股息率
—
52 周区间
0.55 – 2.76
成交量
2.91M
Beta
2.52
目标价
2.05
52W 低 0.5552W 高 2.76
价格走势
公司简介
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would tar...